BioNTech SE

BioNTech SEverified

BNTX

Price:

$113.51

Market Cap:

$26.17B

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122),...[Read more]

Industry

Biotechnology

IPO Date

2019-10-10

Stock Exchange

NASDAQ

Ticker

BNTX

The ROE as of December 2024 (TTM) for BioNTech SE (BNTX) is -2.38%

According to BioNTech SE’s latest financial reports and current stock price. The company's current ROE is -2.38%. This represents a change of 278.81% compared to the average of -0.63% of the last 4 quarters.

BioNTech SE (BNTX) Historical ROE (quarterly & annually)

How has BNTX ROE performed in the past?

The mean historical ROE of BioNTech SE over the last ten years is 32.34%. The current -2.38% ROE has changed -107.37% with respect to the historical average. Over the past ten years (40 quarters), BNTX's ROE was at its highest in in the June 2021 quarter at 50.84%. The ROE was at its lowest in in the September 2020 quarter at -22.64%.

Quarterly (TTM)
Annual

Average

32.34%

Median

2.85%

Minimum

-36.31%

Maximum

173.75%

BioNTech SE (BNTX) ROE by Quarter and Year

Discovering the peaks and valleys of BioNTech SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual ROE = 173.75%

Minimum Annual Increase = -110.38%

Minimum Annual ROE = -36.31%

Quarterly (TTM)
Annual
YearROEChange
20234.60%-90.23%
202247.04%-45.64%
202186.54%7.71%
20201.11%-103.05%
2019-36.31%101.24%
2018-18.04%-110.38%
2017173.75%Infinity%

BioNTech SE (BNTX) Average ROE

How has BNTX ROE performed in the past?

The current ROE of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

46.06%

5-year avg

20.59%

10-year avg

32.34%

BioNTech SE (BNTX) ROE vs. Peers

How is BNTX’s ROE compared to its peers?

BioNTech SE’s ROE is less than Novavax, Inc. (44.82%), greater than CohBar, Inc. (-58.44%), greater than Ginkgo Bioworks Holdings, Inc. (-70.11%), greater than CRISPR Therapeutics AG (-12.15%), less than Ocean Biomedical, Inc. (0%), less than Enveric Biosciences, Inc. (75.64%), greater than Hepion Pharmaceuticals, Inc. (-201.01%), greater than Elevation Oncology, Inc. (-505.74%), greater than AVROBIO, Inc. (-59.73%), less than PTC Therapeutics, Inc. (29.68%), less than Krystal Biotech, Inc. (48.38%), less than Sarepta Therapeutics, Inc. (6.34%), less than Iovance Biotherapeutics, Inc. (11.83%), greater than Madrigal Pharmaceuticals, Inc. (-58.43%), greater than null (-71.78%),

Build a custom stock screener for BioNTech SE (BNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNTech SE (BNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is BioNTech SE's ROE?

How is the ROE calculated for BioNTech SE (BNTX)?

What is the highest ROE for BioNTech SE (BNTX)?

What is the 3-year average ROE for BioNTech SE (BNTX)?

What is the 5-year average ROE for BioNTech SE (BNTX)?

How does the current ROE for BioNTech SE (BNTX) compare to its historical average?